Asia-Pacific Varicose Vein Treatment Market Size, Share, Trends & Growth Forecast Report By Treatment, Product & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of Asia-Pacific), Industry Analysis From 2024 to 2032

Updated On: June, 2024
ID: 2509
Pages: 130

Asia-Pacific Varicose Vein Treatment Market Size

The Asia-Pacific varicose vein treatment market was worth USD 70.33 million in 2023. The Asia-Pacific market is further expected to grow at a CAGR of 6.9% from 2024 to 2032 and be worth USD 128.22 million by 2032 from USD 75.18 million in 2024.

Varicose vein treatment involves a range of medical interventions aimed at addressing varicose veins, a condition characterized by swollen, twisted veins visible under the skin, primarily in the legs. This procedure includes minimally invasive procedures, such as endovenous laser therapy (EVLT), sclerotherapy, and radiofrequency ablation, as well as traditional surgical methods like vein stripping. The rising prevalence of varicose veins in the Asia-Pacific region due to factors such as aging populations, obesity, prolonged standing, and sedentary lifestyles has significantly contributed to the growth of the regional market. Additionally, increasing awareness about advanced treatment options and the availability of innovative technologies have further propelled market expansion.

The Asia-Pacific region is emerging as a rapidly growing segment in the global market due to improved healthcare infrastructure and rising disposable incomes. The region is witnessing a surge in demand for minimally invasive treatments, particularly in countries like China, India, Japan, and South Korea. For instance, Japan, with its rapidly aging population, has seen a notable increase in the adoption of advanced varicose vein treatments. Similarly, India’s growing middle class and increasing healthcare expenditure are driving market growth. The Asia-Pacific varicose vein treatment market is also benefiting from the presence of key players investing in research and development to introduce cost-effective and efficient treatment solutions. As a result, the market is poised for sustained growth, supported by technological advancements and a growing focus on patient-centric care.

MARKET DRIVERS

Aging Population In the Asia-Pacific

The aging population is a key factor propelling the Asia-Pacific varicose vein treatment market. According to the United Nations Population Fund, the number of individuals aged 60 and above in the region is expected to reach nearly 1.3 billion by 2050, a significant increase from current levels. Varicose veins are more common among older adults due to the natural weakening of vein valves and reduced elasticity. For example, Japan, where over 28% of the population is aged 65 or older, as reported by the Statistics Bureau of Japan, has seen a surge in demand for varicose vein treatments. This demographic trend is pushing healthcare systems to adopt advanced and minimally invasive treatment options to cater to the growing elderly population.

Rising Obesity and Sedentary Lifestyles

The increasing prevalence of obesity and sedentary lifestyles is another major driver of the Asia-Pacific varicose vein treatment market. The World Health Organization reports that obesity rates in the region have tripled since 1980, with countries like Malaysia and Thailand experiencing adult obesity rates exceeding 15%. Obesity places additional pressure on leg veins, increasing the risk of varicose veins. Furthermore, sedentary behaviors, particularly in urban areas, contribute to poor blood circulation, exacerbating the condition. Governments and healthcare organizations are actively promoting awareness about the risks associated with obesity and inactivity, which is driving the adoption of varicose vein treatments across the region.

MARKET RESTRAINTS

High Treatment Costs Limiting Accessibility 

One of the primary restraints of the Asia-Pacific varicose vein treatment market is the high cost of advanced treatments. According to the World Health Organization, healthcare expenditure in low- and middle-income countries in the region remains significantly lower compared to developed nations. For instance, in India, out-of-pocket healthcare expenses account for nearly 62% of total health spending, as reported by the National Health Accounts. Minimally invasive procedures like endovenous laser therapy and radiofrequency ablation are often expensive, making them inaccessible to a large portion of the population. This financial barrier restricts the adoption of advanced treatments, particularly in rural and underserved areas, thereby hindering market growth.

Lack of Awareness and Diagnostic Facilities 

Limited awareness about varicose vein treatments and inadequate diagnostic infrastructure are significant challenges in the Asia-Pacific region. The World Bank highlights that healthcare infrastructure in many developing countries, such as Indonesia and the Philippines, remains underdeveloped, with limited access to specialized medical facilities. For example, Indonesia has only 1.2 hospital beds per 1,000 people, as per data from the Ministry of Health of Indonesia. Additionally, a lack of awareness about early symptoms and treatment options often leads to delayed diagnosis and treatment. This gap in knowledge and infrastructure prevents timely intervention, limiting the overall growth of the varicose vein treatment market in the region.

MARKET OPPORTUNITIES

Expansion of Healthcare Infrastructure 

The ongoing expansion of healthcare infrastructure in the Asia-Pacific region presents a significant opportunity for the varicose vein treatment market. Governments across the region are investing heavily in healthcare modernization. For instance, China’s National Health Commission reported that the country’s healthcare expenditure reached USD 1.2 trillion in 2022, with a focus on improving access to advanced medical treatments. Similarly, India’s Ayushman Bharat initiative aims to establish 150,000 health and wellness centers by 2025, enhancing access to specialized care. These developments are expected to increase the availability of varicose vein treatments, particularly in rural and underserved areas, driving market growth.

Rising Adoption of Minimally Invasive Procedures 

The growing preference for minimally invasive treatments offers a substantial opportunity for the varicose vein treatment market. According to the Australian Institute of Health and Welfare, the adoption of minimally invasive procedures, such as endovenous laser therapy and sclerotherapy, has increased by over 20% in the past five years due to their effectiveness and shorter recovery times. Countries like South Korea and Japan are leading this trend, with advanced healthcare systems and high patient awareness. The shift towards less invasive treatments is expected to continue, supported by technological advancements and increasing patient demand for safer, more efficient.

MARKET CHALLENGES

Regulatory Hurdles and Approval Delays 

Regulatory challenges and delays in treatment approvals pose a significant challenge to the Asia-Pacific varicose vein treatment market. According to the World Health Organization, regulatory frameworks in many countries in the region, such as India and Indonesia, are often complex and time-consuming, leading to delays in the introduction of innovative treatments. For example, the Central Drugs Standard Control Organization in India reported that the average approval time for new medical devices can extend up to 18 months. These delays hinder the timely availability of advanced varicose vein treatments, limiting market growth and patient access to cutting-edge therapies.

Shortage of Skilled Healthcare Professionals 

A shortage of skilled healthcare professionals specializing in varicose vein treatments is another major challenge. The World Bank highlights that countries like the Philippines and Vietnam face significant gaps in their healthcare workforce, with fewer than 10 physicians per 10,000 people in some regions. This shortage is particularly acute in rural areas, where access to specialized care is already limited. The lack of trained professionals capable of performing advanced procedures, such as endovenous laser therapy, restricts the adoption of these treatments, thereby impeding market expansion and affecting patient outcomes.

KEY MARKET PARTICIPANTS

Companies that are playing a prominent role in the Asia Pacific Varicose Vein Treatment Market profiled in the report are Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), Merz Aesthetics (U.S.).

MARKET SEGMENTATION

This research report segmented and sub-segmented the Asia-Pacific Varicose Vein Treatment Market into the following categories.

By Treatment Type

  • Surgical Treatments
    • Vein Ligation and Stripping
    • Phlebectomy
  • Non-Surgical Treatments
    • Laser Therapy
    • Trans-Illuminated Powered Phlebectomy (Trivex)
  • Radiofrequency Ablation
    • Sclerotherapy

By Device

  • Ablation devices
    • Radiofrequency Ablation Devices
    • Laser Ablation Devices
  • Venous Closure Products
  • Surgical Products

By End-User

  • Surgery Centres
  • Hospitals
    • Specialty Hospitals
    • Multispecialty Hospitals

By Country 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of Asia-Pacific

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample